Title:
Change discharge dosage forms of a 5-HT2C agonist useful for weight control
Document Type and Number:
Japanese Patent JP6272695
Kind Code:
B2
Abstract:
The present invention relates to methods for weight management that utilize modified-release dosage forms comprising ( R )-8-chloro-1-methyl-2,3,4,5-tetrahydro-1 H -3-benzazepine salts and crystalline forms thereof. The present invention further relates to ( R )-8-chloro-1-methyl-2,3,4,5-tetrahydro-1 H -3-benzazepine salts, crystalline forms thereof and modified-release dosage forms comprising them.
Inventors:
Xiao, Zazi Jessie
Blackburn, Anthony Sea.
Grottic, Andrew Jay.
Morgan, Michael
Router, Jamie Karin
Shifrina, Anna
Stillon, Scott
Young, revo
Yun, Woo Hyun
Blackburn, Anthony Sea.
Grottic, Andrew Jay.
Morgan, Michael
Router, Jamie Karin
Shifrina, Anna
Stillon, Scott
Young, revo
Yun, Woo Hyun
Application Number:
JP2013527255A
Publication Date:
January 31, 2018
Filing Date:
August 31, 2011
Export Citation:
Assignee:
Eisai R & D Management Co., Ltd.
International Classes:
A61K31/55; A61K9/20; A61K31/137; A61K31/155; A61K45/00; A61K47/10; A61K47/12; A61K47/38; A61P3/04; A61P43/00
Other References:
.「コントロールリリース技術」,2003年6月27日普及版第1刷発行,島健太郎発行,株式会社シーエムシー出版,第11頁~第14頁中段
Attorney, Agent or Firm:
Hidesaku Yamamoto
Natsuki Morishita
Natsuki Morishita
Previous Patent: O - The ester of the replaced hydroxycarboxylic acid, and its manufacture
Next Patent: JPS6272696
Next Patent: JPS6272696